[Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Interferon combined with cytostatics yielded in multiple myeloma more objective reactions than conventional chemotherapy. Survival time elongation was achieved solely by maintaining myeloma remissions with long term interferon administration. In non-Hodgkin's lymphoma combinations of cytostatics with interferon were more effective than conventional chemo-and radiotherapy only when used in low grade lymphomas of the nodular type. Evidence for longer survival of these patients still waits for presentation.
Gola
A
A
Kliniki Hematologii i Chorób Rozrostowych AM we Wrocławiu.
D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D007372:Interferons